The identification of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families

Clinical Endocrinology

Volumn 44, Issue 2, 1996, Pages 213-220

  Marsh, Debbie J ^a,b   McDowall, Deborah ^a   Hyland, Valentine J ^a,b   Andrew, Scott D ^a,b   Schnitzler, Margaret ^a,b   Gaskin, Elizabeth L ^a,b   Nevell, David F ^a   Diamond, Terrence ^c   Delbridge, Leigh ^a   Clifton Bligh, Phillip ^a   Robinson, Bruce G ^a,b  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ST GEORGE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; PARATHYROID HORMONE; PENTAGASTRIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUTATION; PRIORITY JOURNAL; SIPPLE SYNDROME; THYROIDECTOMY;

EID: 9044232867     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.505292.x     Document Type: Article

References (36)

1. Albores-Saavedra, J., Monforte, H., Nadji, M. & Morales, A.R. (1988) C-cell hyperplasia in thyroid tissue adjacent to follicular cell tumours. Human Pathology, 19, 795-799.
2. Barbot, N., Calmettes, C., Schuffenecker, I., Saint-Andre, J.P., Franc, B., Rohmer, V., Jallet, P. & Bigorgne, J.C. (1994) Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma. Journal of Clinical Endocrinology & Metabolism, 78, 114-120.
3. Carlson, K.M., Dou, S., Chi, D., Scavarda, N., Toshima, K., Jackson, C.E., Wells, S.A., Goodfellow, P.J. & Donis-Keller H. (1994) Single missense mutation in the tyrosine kinase catalytic domain of the RET proto-oncogene is associated with multiple endocrine neoplasia type 2B. Proceedings of the National Academy of Science, 91, 1579-1583.
4. Chi, D.D., Toshima, K., Donis-Keller, H. & Wells, S.A. (1994) Predictive testing for multiple endocrine neoplasia type 2A (MEN 2A) based on the detection of mutations in the RET protooncogene. Surgery, 116, 124-133.
5. Deftos, L.J., Weisman M.H., Williams, G.W., Karpf, D.B., Frumar, A.M., Davidson, B.J., Parthemore, J.G. & Judd, H.L. (1980) Influence of age and sex on plasma calcitonin in human beings. New England Journal of Medicine, 302, 1351-1353.
6. Donis-Keller, H., Dou, S., Chi, D., Carlson, K.M., Toshima, K., Lairmore, T.C. Howe, J.R., Moley, J.F., Goodfellow, P. & Wells Jr, S.A. (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Human Molecular Genetics, 2, 851-856.
7. Eng, C., Smith, D.P., Mulligan, L.M., Nagai, M.A., Healey, C.S., Ponder, M.A., Gardner, E., Scheumann, G.F.W., Jackson, C.E., Tunnacliffe, A. & Ponder, B.A.J. (1994) Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Human Molecular Genetics, 3, 237-241.
8. Escalada, J., Teruel, J.L., Pavon, I., Vila, T., Navarro, J. & Varela, C. (1993) Normal calcitonin response to pentagastrin stimulation in patients with chronic renal failure. Acta Endocrinologica, 129, 39-41.
9. Furlong, T., Chan, Y.L., Cornish, C., McDowall, D., Mahony, J. & Clifton-Bligh, P. (1991) Immunoreactive serum calcitonin and skeletal histology in chronic renal failure. Nephron, 58, 138-143.
10. Gagel, R.F., Tashjian, A.H., Cummings, T., Papathanasopoulos, N., Kaplan, M.M., DeLellis, R.A., Wolfe, H.F. & Reichlin, S. (1988) The clinical outcome of prospective screening for multiple endocrine neoplasia type 2A. An 18-year experience. New England Journal of Medicine, 318, 478-484.
11. Garancini, S., Ballada, L., Roncari, G. & Gastaldi, L. (1983) Calcitonin in chronic renal failure. Nephron, 34, 224-227.
12. Gibson W.G.H., Peng T.C. & Croker, B.P. (1982) Age-associated C-cell hyperplasia in the human thyroid. American Journal of Pathology, 106, 388-393.
13. Grauer A., Raue, F. & Gagel, R.F. (1990) Changing concepts in the management of hereditary and sporadic medullary thyroid carcinoma. Endocrinology & Metabolism Clinics of North America, 19, 613-635.
14. Graze, K., Spiler, I.J., Tashjian, A.H., Melvin, K.E.W., Cervi-Skinner, S., Gagel, R.F., Miller, H.H., Wolfe, H.J., DeLellis, R.A., Leape, L. & Feldman, Z.T. (1978) Natural history of familial medullary thyroid carcinoma. Effect of a program for early diagnosis. New England Journal of Medicine, 299, 980-985.
15. Guilloteau, D. Perdrisot, R., Calmettes, C., Baulieu, J.L., Lecomte, P., Kaphan, G., Milhaud, G., Besnard, J.C., Jallet, P. & Bigorgne, J.C. (1990) Diagnosis of medullary carcinoma of the thyroid (MCT) by calcitonin assay using monoclonal antibodies: criteria for the pentagastrin stimulation test in hereditary MCT. Journal of Clinical Endocrinology & Metabolism, 71, 1064-1067.
16. Hein, M.D., Monchik, J.M. & Jackson, I.M.D. (1989) Pentagastrin stimulation of calcitonin in phacochromocytoma does not always indicate multiple endocrine neoplasia type II. Journal of Endocrinological Investigation, 12, 265-267.
17. Heynen, G. & Franchimont, P. (1974) Human calcitonin radioimmunoassay in normal and pathologic conditions. European Journal of Clinical Investigation, 6, 213-222.
18. Hofstra, R.M.W., Landsvater, R.M., Ceccherini, I., Stulp, R.P., Stelwagen, T., Luo, Y., Pasini, B., Höppener, J.W.M., van Amstel, H.K.P., Romeo, G., Lips, C.J.M. & Buys, C.H.C.M. (1994) A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature, 367, 375-376.
19. Hsu, S., Raine, L. & Fanger, H. (1981) A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptidc hormones with radioimmunoassay antibodies. American Journal of Clinical Pathology, 75, 734-738.
20. Kao, P.C. & Gharib, H. (1993) Clinical performance of an extraction calcitonin radioimmunoassay. Mayo Clinical Proceedings, 68, 1165-1170.
21. Landsvater, R.M., Rombouts, A.G.M., te Meerman, G.J., Schillhorn-van Veen, J.M.J., Berends, M.J.H., Geerdink, R.A., Struyvenberg, A., Buys, C.H.C.M. & Lips, C.J.M. (1993) The clinical implications of a positive calcitonin test for C-cell hyperplasia in genetically unaffected members of an MEN 2A kindred. American Journal of Human Genetics, 52, 335-342.
22. Lips, C.J.M., Leo, J.R., Berends, M.J.H., Minder, W.H., Blok, A.P.R., Geerdink, R.A., Hackeng, W.H.L., Roelofs, J.M.M, Vasen, H.F.A. & Vette, J.K. (1987) Thyroid C-cell hyperplasia and micronodules in close relatives of MEN-2A patients: pitfalls in early diagnosis and reevaluation of criteria for surgery. Henry Ford Hospital Medical Journal, 35, 133-138.
23. Lips, C.J.M., Landsvater, R.M., Höppener, J.W.M., Geerdink, R.A., Blijham, G., Jansen-Schillhorn van Veen, J.M., van Gils, A.P.G., de Wit, M.J., Zewald, R.A., Berends, M.J.H., Beemer, F.A., Brouwers-Smalbraak, J., Jansen, R.P.M., Ploos van Amstel, H., van Vroonhoven, T.J.M.V. & Vroom, T.M. (1994) Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. The New England Journal of Medicine, 331, 828-835.
24. Marsh, D.J., Robinson, B.G., Andrew, S., Richardson, A., Pojer, R., Schnitzler, M., Mulligan, L.M. & Hyland, V.J. (1994) A rapid screening method for the detection of mutations in the RET proto-oncogene in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma families. Genomics, 23, 477-479.
25. Marx, S., Woodward, C., & Aurbach, G. (1972) Calcitonin receptors of kidney and bone. Science, 178, 999-1001.
26. McMahon R., Mulligan, L.M., Healey, C.S., Payne, S.J., Ponder, M., Ferguson-Smith, M.A., Barton, D.E. & Ponder, B.A.J. (1994) Direct, non-radioactive detection of mutations in multiple endocrine neoplasia type 2a families. Human Molecular Genetics, 3, 643-646.
27. Milhaud, G., Calmette, C., Taboulet, J., Julienne, A. & Moukhtar, M.S. (1974) Hypersecretion of calcitonin in neoplastic conditions. Lancet, 1, 462-463.
28. Mulder, H., Silberbusch, J., Hackeng, W.H.L., Koorevaar, G. & den Ottolander, G.J.H. (1982) Enhanced calcitonin release in chronic renal failure depending on the absence of severe secondary hyperparathyroidism. Nephron, 31, 123-128.
29. Mulligan, L.M., Kwok, J.B.J., Healey, C.S., Elsdon, M.J., Eng, C., Gardner, E., Love, D.R., Mole, S.E., Moore, J.K., Papi, L., Ponder, M.A., Telenius, H., Tunnacliffe, A. & Ponder, B.A.J. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature, 363, 458-460.
30. Mulligan, L.M., Eng, C., Healey, C.S., Clayton, D., Kwok, J.B.J., Ponder, M.A., Frilling, A., Jackson, C.E., Lehnert, H., Neumann, H.P.H., Thibodeau, S.N. & Ponder, B.A.J. (1994) Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nature Genetics, 6, 70-74.
31. Price, D.E., Absalom S.R., Davidson, K., Bolia, A., Bell, P.R.F. & Howlett, T.A. (1992) A case of multiple endocrine neoplasia: hyperparathyroidism, insulinoma, GRF-oma, hypercalcitoninacmia and intractable peptic ulceration. Clinical Endocrinology, 37, 187-188.
32. Silva, O.L., Becker, K.L., Shalhoub, R.J., Snider, R.H., Bivins, L.E. &. Moore, C.F. (1977) Calcitonin levels in chronic renal disease. Nephron, 19, 12-18.
33. Wells, S.A., Chi, D.D., Toshima, K., Dehner, L.P., Coffin, C.M., Dowton, B., Ivanovich, J.L., DeBenedetti, M.K., Dilley, W.G., Moley, J.F., Norton, J.A., Donis-Keller, H. (1994) Predictive DNA testing and prophylactic throidectomy in patients at risk for multiple endocrine neoplasia type 2A. Annals of Surgery, 220, 237-250.
34. Wolfe, H.J., Melvin, K.E.W., Cervi-Skinner, S.J., Al Saadi, A.A. Juliar, J.F., Jackson, C.E. & Tashjian, A.H. (1973) C-cell hyperplasia preceding medullary thyroid carcinoma. New England Journal of Medicine, 289, 437-441.
35. Wolfe H.J., Voelkel, E.F. & Tashjian, A.H. (1974) Distribution of calcitonin-containing cells in the normal adult human thyroid gland: a correlation of morphology with peptide content. Journal of Clinical Endocrinology & Metabolism, 38, 688-694.
36. Xue, F., Yu, H., Maurer, L.H., Memoli, V.A., Nutile-McMenemy, N., Schuster, M.K., Bowden, D.W., Mao, J. & Noll, W. (1994) Germline RET mutations in MEN 2A and FMTC and their detection by simple DNA diagnostic tests. Human Molecular Genetics, 3, 635-638.